Shutterstock SSTK 深 沪
等待开盘 12-20 09:30:00 美东时间
18.315
-0.550
-2.92%
华盛通- 最 高21.68
- 今 开18.78
- 成交量 24.03万股
- 最 低 17.92
- 昨 收 18.865
- 总市值 6.70亿
- 52周最高 38.80
- 市盈率 静 7.44
- 换手率 0.66%
- 52周最低 14.35
- 委 比 -81.25%
- 总股本 3658.96万
- 历史最高 127.67
- 量 比 0.96
- 振 幅 19.93%
- 历史最低 14.35
- 每 手 1
- 风险率 4.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Deal Dispatch: Snoopy, TikTok, Trump And The Weeknd Are In The Mix
Plus: Global M&A activity surged in 2025, with announced deal value climbing 46% year over year to about $4.4 trillion.
今天 04:45
Nuclear's Comeback Trade: Why Tortoise Launched A Full-Stack Nuclear ETF
Tortoise's Matt Sallee breaks down the macro forces behind the new Nuclear Renaissance ETF (TNUK), from AI power demand to nuclear policy tailwinds.
今天 04:01
Ethereum Faces Uncertain 2026: The Missing Ingredient(s) To Catch BTC
Ethereum (CRYPTO: ETH) sits at the centre of one of crypto's longest-running debates: does it function as a true form of "cryptomoney" like Bitcoin or primarily as a t
今天 03:14
Space Wars, AI Drones, And Wall Street's New Favorite Trade
KeyBanc's ratings and price forecasts for space and defense companies reflect strong growth potential in the sector.
今天 02:27
Stock Of The Day: Will The Tesla Breakout Hold?
Tesla shares have broken out. If what had been resistance converts into support it could set the stage for a move higher.
今天 02:19
What's Going On With Cruise Ship Stocks Friday?
Shares of cruise ship stocks are trading higher Friday amid sympathy with Carnival after the company reported fourth quarter financial results.
今天 02:14
5 Stocks Flashing Technical Warnings Signs for 2026
Markets are volatile, AI rally shows cracks, outlook uncertain. Technical analysis used to predict short-term moves. 5 stocks to sell before New Year.
今天 02:09
Altimmune's MASH Drug Shows Durable Liver, Weight Loss Gains At 48 Weeks
Altimmune reports positive 48-week Phase 2b data for pemvidutide in MASH, showing fibrosis improvement, weight loss, and strong tolerability.
今天 01:57
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out
Merck declines its option on Evaxion's EVX-B2 gonorrhea vaccine, leaving global rights with Evaxion and no change to its cash runway through 2027.
今天 01:43
Cintas Analysts Boost Their Forecasts Following Upbeat Earnings
Cintas Corporation (NASDAQ:CTAS) posted upbeat quarterly profit and raised its ...
今天 01:26
